MedTrace Logo

Proving Hemodilution in a Human Model for Class I Hemorrhage

NCT02318355 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 165

Last updated 2022-04-21

No results posted yet for this study

Summary

This study is a randomized control trial in volunteer blood donors to quantify the effect of blood loss and subsequent crystalloid infusion on hemoglobin and markers of resuscitation such as base deficit and lactate.

Conditions

  • Hemodilution
  • Hemorrhage
  • Shock
  • Wounds and Injuries

Interventions

OTHER

normal saline

Crystalloid intravenous solution

OTHER

lactated ringers

Crystalloid intravenous solution

Sponsors & Collaborators

  • Community Blood Center of the Carolinas

    collaborator UNKNOWN

  • Wake Forest University Health Sciences

    lead OTHER

Principal Investigators

  • Ronald F Sing, DO · Professor of Surgery

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2014-06-30
Completion
2014-06-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02318355 on ClinicalTrials.gov